GB2187191B - Protection of proteins and the like - Google Patents

Protection of proteins and the like

Info

Publication number
GB2187191B
GB2187191B GB8704890A GB8704890A GB2187191B GB 2187191 B GB2187191 B GB 2187191B GB 8704890 A GB8704890 A GB 8704890A GB 8704890 A GB8704890 A GB 8704890A GB 2187191 B GB2187191 B GB 2187191B
Authority
GB
United Kingdom
Prior art keywords
proteins
protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8704890A
Other versions
GB8704890D0 (en
GB2187191A (en
Inventor
Bruce Joseph Roser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Bioresources Ltd
Original Assignee
Quadrant Bioresources Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2187191(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858517352A external-priority patent/GB8517352D0/en
Priority claimed from GB868613066A external-priority patent/GB8613066D0/en
Application filed by Quadrant Bioresources Ltd filed Critical Quadrant Bioresources Ltd
Priority to GB8704890A priority Critical patent/GB2187191B/en
Priority claimed from PCT/GB1986/000396 external-priority patent/WO1987000196A1/en
Publication of GB8704890D0 publication Critical patent/GB8704890D0/en
Publication of GB2187191A publication Critical patent/GB2187191A/en
Application granted granted Critical
Publication of GB2187191B publication Critical patent/GB2187191B/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
GB8704890A 1984-01-30 1986-07-09 Protection of proteins and the like Expired GB2187191B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8704890A GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57509184A 1984-01-30 1984-01-30
GB858517352A GB8517352D0 (en) 1985-07-09 1985-07-09 Protection of proteins
GB868613066A GB8613066D0 (en) 1986-05-29 1986-05-29 Protection of proteins &c
GB8704890A GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like
PCT/GB1986/000396 WO1987000196A1 (en) 1985-07-09 1986-07-09 Protection of proteins and the like

Publications (3)

Publication Number Publication Date
GB8704890D0 GB8704890D0 (en) 1987-04-08
GB2187191A GB2187191A (en) 1987-09-03
GB2187191B true GB2187191B (en) 1989-11-01

Family

ID=27449677

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8704890A Expired GB2187191B (en) 1984-01-30 1986-07-09 Protection of proteins and the like

Country Status (1)

Country Link
GB (1) GB2187191B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US8168223B1 (en) 1997-09-29 2012-05-01 Novartis Pharma Ag Engineered particles and methods of use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
GB2350046B (en) 1999-05-20 2002-12-18 British Sugar Plc Edible compositions containing trehalose
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1855591A (en) * 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
FR2406999A1 (en) * 1977-10-27 1979-05-25 Behringwerke Ag STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
FR2532178A1 (en) * 1982-08-31 1984-03-02 Asahi Chemical Ind PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME
EP0111216A2 (en) * 1980-03-31 1984-06-20 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
EP0140489A1 (en) * 1983-08-05 1985-05-08 Wako Pure Chemical Industries, Ltd. Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1855591A (en) * 1926-02-03 1932-04-26 Wallerstein Co Inc Invertase preparation and method of making the same
FR2406999A1 (en) * 1977-10-27 1979-05-25 Behringwerke Ag STABILIZER FOR MENINGOCOCCAL POLYSACCHARIDES
GB2009198A (en) * 1977-10-27 1979-06-13 Behringwerke Ag Stabilized polysaccharides
GB2016687A (en) * 1978-03-20 1979-09-26 Abbott Lab Sugar Coated Reagents for Solid Phase Immunoassay
EP0111216A2 (en) * 1980-03-31 1984-06-20 Takeda Chemical Industries, Ltd. Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
FR2532178A1 (en) * 1982-08-31 1984-03-02 Asahi Chemical Ind PROCESS FOR STABILIZING TUMOR NECROSIS FACTOR AND AQUEOUS SOLUTION OR STABLE POWDER CONTAINING THE SAME
GB2126588A (en) * 1982-08-31 1984-03-28 Asahi Chemical Ind A method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing the same
EP0140489A1 (en) * 1983-08-05 1985-05-08 Wako Pure Chemical Industries, Ltd. Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Patent Abstracts of Japan,Volume 9,No.323 JP A 60149972 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7780991B2 (en) 1994-12-02 2010-08-24 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7785631B2 (en) 1994-12-02 2010-08-31 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US8168223B1 (en) 1997-09-29 2012-05-01 Novartis Pharma Ag Engineered particles and methods of use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery

Also Published As

Publication number Publication date
GB8704890D0 (en) 1987-04-08
GB2187191A (en) 1987-09-03

Similar Documents

Publication Publication Date Title
DE3666855D1 (en) Alcalisilicate compositions and their use
GB8412564D0 (en) Structure and properties
IL78934A0 (en) Alfuzosine compositions and use
ZA859339B (en) Processes and compositions
GB2176489B (en) Polypeptide and polypeptide composition
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
GB2164044B (en) -hanp related polypeptides and their use
GB2168065B (en) Polyanhydride-siloxanes and polyimide-siloxanes obtained therefrom
GB2159160B (en) Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides
DE3565257D1 (en) Hydroxyalkylcycloalkylbenzeneacetamides and benzamides
EP0165753A3 (en) Herbicidal thiophenesulfonamides and pyridinesulfonamides
ZA853379B (en) Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents
GB2187191B (en) Protection of proteins and the like
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
EP0230052A3 (en) Immunoamplifiers and related compositions
ZA855612B (en) N-arylsulfonyl-n'-triazinylureas and n-arylsulfonyl-n'-pyrimidinyl-ureas
DE3563624D1 (en) Novel substituted trifluorooxetane and preparation thereof
AU4617185A (en) Ketofin and anti-asthmatically effective xanthine
AU568750B2 (en) Imidazo-pyrrolo-pyridines and their use as herbacides
EP0162690A3 (en) 2-oxa-spirocyclic-benzeneacetamides and benzamides
GB8820199D0 (en) Protective materials and application thereof
PH20880A (en) Substituted benzoxepines and isochromanes
GB8414999D0 (en) Protection of surfaces

Legal Events

Date Code Title Description
708B Proceeding under section 8(1) patents act 1977
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
775O Application for amendment (sect. 75/1977) open to opposition
775L Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977)
775L Amendment of patent in infringement or revocation proceedings. application to amend not proceeded with (sect. 75/1977)
SP Amendment (slips) printed
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20060708